Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX) and Quanterix (QTRX)
TipRanks (Wed, 27-Mar 7:00 AM ET)
Quanterix’s Strong IP Position Fuels Buy Rating in Alzheimer’s Diagnostic Market
TipRanks (Wed, 27-Mar 2:56 AM ET)
Analysts Are Bullish on Top Healthcare Stocks: Quanterix (QTRX), Passage Bio (PASG)
TipRanks (Tue, 26-Mar 7:20 AM ET)
TipRanks (Sun, 24-Mar 9:30 PM ET)
Business Wire (Thu, 21-Mar 5:30 PM ET)
Business Wire (Mon, 4-Mar 9:00 AM ET)
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023
Business Wire (Thu, 29-Feb 4:00 PM ET)
Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance
Business Wire (Mon, 26-Feb 6:58 PM ET)
Business Wire (Mon, 26-Feb 9:00 AM ET)
Quanterix to Present at Cowen's 44th Annual Health Care Conference
Business Wire (Fri, 23-Feb 4:30 PM ET)
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.
Quanterix trades on the NASDAQ stock market under the symbol QTRX.
As of March 28, 2024, QTRX stock price climbed to $23.56 with 229,417 million shares trading.
QTRX has a beta of 0.40, meaning it tends to be less sensitive to market movements. QTRX has a correlation of 0.00 to the broad based SPY ETF.
QTRX has a market cap of $891.27 million. This is considered a Small Cap stock.
Last quarter Quanterix reported $32 million in Revenue and -$.33 earnings per share. This beat revenue expectation by $2 million and missed earnings estimates by -$.01.
In the last 3 years, QTRX stock traded as high as $69.22 and as low as $6.31.
The top ETF exchange traded funds that QTRX belongs to (by Net Assets): VTI, IWM, VXF, IWN, IBB.
QTRX has outperformed the market in the last year with a return of +122.5%, while the SPY ETF gained +33.9%. However, in the most recent history, QTRX shares have underperformed the stock market with its stock returning -16.5% in the last 3 month period and -10.5% for the last 2 week period, while SPY has returned +10.3% and +1.9%, respectively.
QTRX support price is $21.99 and resistance is $23.87 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that QTRX stock will trade within this expected range on the day.